Cue Biopharma Income Statement (2017-2025) | CUE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue						0.17M	0.45M	0.33M	0.37M	1.05M	0.98M	1.05M	0.90M	1.07M	0.70M	0.48M	1.55M	2.74M	2.40M	8.25M	1.00M	0.03M	0.07M	0.15M	0.19M	1.38M	2.10M	1.82M	1.72M	2.66M	3.34M	1.58M	0.42M	2.95M	2.15M
Operating items
Research & Development					5.82M	5.41M	10.31M	6.82M	8.35M	6.87M	5.30M	6.96M	9.91M	8.12M	7.52M	8.00M	9.82M	8.76M	11.29M	11.50M	10.08M	9.59M	7.57M	11.33M	9.39M	10.65M	9.87M	10.89M	10.20M	9.53M	9.38M	7.18M	8.55M	7.91M	4.75M
Selling, General & Administrative					1.70M	2.23M	2.90M	4.47M	3.44M	3.42M	2.78M	3.10M	3.99M	3.90M	3.32M	3.45M	4.25M	4.28M	4.12M	4.65M	5.16M	3.78M	3.53M	3.70M	4.18M	4.25M	3.65M	4.61M	4.19M	3.51M	2.87M	4.02M	4.17M	3.68M	4.94M
Other Operating Expenses																						-0.26M		-0.02M				-0.16M			0.10M	-0.00M			0.05M
Operating Expenses					7.52M	7.64M	13.21M	11.30M	11.80M	10.29M	8.08M	10.06M	13.89M	12.02M	10.84M	11.45M	14.07M	13.04M	15.41M	16.15M	15.24M	13.12M	11.10M	15.02M	13.57M	14.90M	13.52M	15.65M	14.38M	13.04M	12.15M	11.21M	12.72M	11.59M	9.74M
Operating Income					-7.52M	-7.47M	-12.76M	-10.97M	-11.43M	-9.23M	-7.09M	-9.02M	-12.99M	-10.94M	-10.13M	-10.97M	-12.52M	-10.30M	-13.02M	-7.89M	-14.24M	-13.09M	-11.03M	-14.87M	-13.38M	-13.52M	-11.42M	-13.83M	-12.67M	-10.38M	-8.81M	-9.63M	-12.30M	-8.63M	-7.59M
EBIT					-7.52M	-7.47M	-12.76M	-10.97M	-11.43M	-9.23M	-7.09M	-9.02M	-12.99M	-10.94M	-10.13M	-10.97M	-12.52M	-10.30M	-13.02M	-7.89M	-14.24M	-13.09M	-11.03M	-14.87M	-13.38M	-13.52M	-11.42M	-13.83M	-12.67M	-10.38M	-8.81M	-9.63M	-12.30M	-8.63M	-7.59M
Non-operating items
Interest & Investment Income						0.17M	0.10M	0.10M	0.11M	0.10M	0.10M	0.17M	0.18M	0.11M	0.10M	0.08M	0.01M	0.02M	0.03M	0.00M	0.01M	0.09M	0.20M	0.63M	0.64M	0.56M	0.70M	0.91M	0.56M	0.43M	0.34M	0.29M	0.17M	0.20M	0.22M
Other Non Operating Income					-0.00M	0.00M	0.10M	0.07M	0.05M	0.03M	0.01M	-0.01M	-0.03M	-0.03M	-0.02M
Non Operating Income					-0.00M	0.17M	0.20M	0.17M	0.16M	0.12M	0.10M	0.10M	0.18M	0.11M	0.10M	0.08M	0.01M	0.02M	0.03M	0.00M	-0.02M	-0.12M	0.08M	0.27M	0.27M	0.33M	0.41M	0.40M	0.32M	0.21M	0.15M	0.14M	0.04M	0.15M	0.15M
Net income details
EBT					-7.52M	-7.30M	-12.56M	-10.80M	-11.31M	-9.11M	-6.99M	-8.92M	-12.82M	-10.83M	-10.03M	-10.90M	-12.51M	-10.28M	-12.99M	-7.89M	-14.26M	-13.21M	-10.96M	-14.23M	-12.74M	-12.95M	-10.72M	-12.93M	-12.11M	-9.96M	-8.47M	-9.34M	-12.13M	-8.44M	-7.37M
Tax Provisions										0.41M		-500.00
Profit After Tax					-7.52M	-7.30M	-12.55M	66.34M	-11.27M	-9.52M	-6.99M	-8.92M	-12.82M	-10.83M	-10.03M	-11.10M	-12.51M	-10.28M	-12.99M	-8.38M	-14.26M	-13.21M	-10.96M	-14.59M	-13.11M	-13.19M	-11.01M	-13.43M	-12.35M	-10.17M	-8.66M	-9.50M	-12.26M	-8.48M	-7.45M
Income from Continuing Operations					-7.52M	-7.30M	-12.56M	-10.80M	-11.31M	-9.52M	-6.99M	-8.92M	-12.82M	-10.83M	-10.03M	-10.90M	-12.51M	-10.28M	-12.99M	-7.89M	-14.26M	-13.21M	-10.96M	-14.23M	-12.74M	-12.95M	-10.72M	-12.93M	-12.11M	-9.96M	-8.47M	-9.34M	-12.13M	-8.44M	-7.37M
Consolidated Net Income					-7.52M	-7.30M	-12.56M	-10.80M	-11.31M	-9.52M	-6.99M	-8.92M	-12.82M	-10.83M	-10.03M	-10.90M	-12.51M	-10.28M	-12.99M	-7.89M	-14.26M	-13.21M	-10.96M	-14.23M	-12.74M	-12.95M	-10.72M	-12.93M	-12.11M	-9.96M	-8.47M	-9.34M	-12.13M	-8.44M	-7.37M
Income towards Parent Company					-7.52M	-7.30M	-12.56M	-10.80M	-11.31M	-9.52M	-6.99M	-8.92M	-12.82M	-10.83M	-10.03M	-10.90M	-12.51M	-10.28M	-12.99M	-7.89M	-14.26M	-13.21M	-10.96M	-14.23M	-12.74M	-12.95M	-10.72M	-12.93M	-12.11M	-9.96M	-8.47M	-9.34M	-12.13M	-8.44M	-7.37M
Net Income towards Common Stockholders					-7.52M	-7.30M	-12.56M	-10.80M	-11.31M	-9.52M	-6.99M	-8.92M	-12.82M	-10.83M	-10.03M	-10.90M	-12.51M	-10.28M	-12.99M	-7.89M	-14.26M	-13.21M	-10.96M	-14.23M	-12.74M	-12.95M	-10.72M	-12.93M	-12.11M	-9.96M	-8.47M	-9.34M	-12.13M	-8.44M	-7.37M
Additional items
EPS (Basic)					-0.37	-0.36	-0.62	3.30	-0.54	-0.46	-0.31	-0.36	-0.48	-0.38	-0.34	-0.36	-0.41	-0.33	-0.41	-0.25	-0.44	-0.37	-0.31	-0.40	-0.29	-0.29	-0.24	-0.29	-0.25	-0.20	-0.17	-0.17	-0.17	-0.09	-0.07
EPS (Weighted Average and Diluted)																			-0.41	-0.25	-0.44	-0.37	-0.31	-0.40	-0.29	-0.29	-0.24	-0.29	-0.25	-0.20	-0.17	-0.17	-0.17	-0.09	-0.07
Shares Outstanding (Weighted Average)	10.64M	10.64M	10.64M	10.73M	20.06M	20.13M	20.13M	20.13M	20.72M	20.82M	22.45M	22.04M	26.57M	28.22M	29.65M	28.69M	30.43M	31.23M	31.32M	31.29M	32.64M	35.36M	35.38M	35.65M	44.65M	44.80M	46.36M	45.75M	49.47M	50.17M	51.23M	56.33M	74.25M	95.46M	100.87M
Shares Outstanding (Diluted Average)																			31.32M	31.29M	32.64M	35.36M	35.38M	35.65M	44.65M	44.80M	46.36M	45.75M	49.47M	50.17M	51.23M	56.33M	74.25M	95.46M	100.87M
EBITDA					-7.52M	-7.30M	-12.58M	66.37M	-11.27M	-9.52M	-6.99M	-8.93M	-12.56M	-10.93M	-9.95M	-11.17M	-12.51M	-10.28M	-12.99M	-8.38M	-14.26M	-13.21M	-11.05M	-14.60M	-13.05M	-13.15M	-11.00M	-13.43M	-12.35M	-10.17M	-8.66M	-9.50M	-12.26M	-8.48M	-7.45M
Interest Expenses																					0.03M	0.21M	0.12M
Tax Rate										-4.53%		0.01%

Research Tools

Cue Biopharma Income Statement (2017-2025) | CUE

Create an account

Sign In

Reset Password